Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-23-149315
Filing Date
2023-05-19
Accepted
2023-05-19 16:09:15
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d487902d424b5.htm 424B5 538369
2 GRAPHIC g487902g00q05.jpg GRAPHIC 135231
3 GRAPHIC g487902g01p31.jpg GRAPHIC 46352
4 GRAPHIC g487902g42h54.jpg GRAPHIC 47748
  Complete submission text file 0001193125-23-149315.txt   844479
Mailing Address 200 POWDER MILL ROAD WILMINGTON DE 19803
Business Address 200 POWDER MILL ROAD WILMINGTON DE 19803 (302) 547-3768
Prelude Therapeutics Inc (Filer) CIK: 0001678660 (see all company filings)

EIN.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-261019 | Film No.: 23940124
SIC: 2834 Pharmaceutical Preparations